SourceOne launches new website

SourceOne® Global Partners LLC, a leading provider of health and wellness solutions created through scientific research and innovative product development, has announced the launch of a new website, Source-1-global.com. 

SourceOne’s new website reflects the depth and breadth of the IP portfolio and expanded product line it has developed and globally launched from 2003 to 2013.

To effectively accommodate site visitors' needs and preferences, the new website was developed to provide customers with useful and valuable product information along with the best user experience.

"We have strengthened and expanded our innovation and technology platform while accelerating the rate of development of new patented formulations," says Jesse Lopez, president and founder of SourceOne. "In addition, we have increased our international and domestic partnerships with leading nutritional supplement companies, which in turn, increased consumer awareness of the many advantages of our tech-driven natural product offerings. Our new website now more accurately reflects our market maturation."

On SourceOne’s website, visitors focused on innovation and new science-backed technologies can quickly learn about next-generation ingredients, such as triple-strength AlivEL 3X100® and double-strength Cholesstrinol HPe® with eriocitrin. In addition, updates include detailed information about more than 15 new patented VESIsorb® formulations. OmegaKrill 5X™ is a breakthrough VESIsorb® formulation  developed in partnership with Aker BioMarine, the Oslo, Norway-based originator of Superba™ krill oil, and Solutex of Madrid, Spain, producer of Omega Choice®, which utilizes a super critical CO2 extraction process for optimal purity omega-3 fish oil.

"The industry continues to become increasingly sophisticated and as a supplier, it is incumbent upon us to be able to deliver to our site visitors easy-to-read, easy-to-navigate information that allows them to take their next important step in product development," Lopez adds.